关注
Dominik Bogen
Dominik Bogen
Incyte Biosciences Germany GmbH
在 incyte.com 的电子邮件经过验证
标题
引用次数
引用次数
年份
Comprehensive genomic analysis of rhabdomyosarcoma reveals a landscape of alterations affecting a common genetic axis in fusion-positive and fusion-negative tumors
JF Shern, L Chen, J Chmielecki, JS Wei, R Patidar, M Rosenberg, ...
Cancer discovery 4 (2), 216-231, 2014
7372014
Aurora B kinase is a potent and selective target in MYCN-driven neuroblastoma
D Bogen, JS Wei, DO Azorsa, P Ormanoglu, E Buehler, R Guha, JM Keller, ...
Oncotarget 6 (34), 35247, 2015
582015
Heterogeneous MYCN amplification in neuroblastoma: a SIOP Europe Neuroblastoma Study
AP Berbegall, D Bogen, U Pötschger, K Beiske, N Bown, V Combaret, ...
British journal of cancer 118 (11), 1502-1512, 2018
532018
The genetic tumor background is an important determinant for heterogeneous MYCN‐amplified neuroblastoma
D Bogen, C Brunner, D Walder, A Ziegler, R Abbasi, RL Ladenstein, ...
International journal of cancer 139 (1), 153-163, 2016
402016
Hepatitis C Virus-Induced Secretion of Inflammatory Chemokines Preferentially Recruits NKG2A+CD8+ T Cells
J Nattermann, R Sherzada, A Iwan, D Bogen, IM Niederle, D Schulte, ...
The Journal of infectious diseases 198 (2), 213-217, 2008
102008
Machine learning framework incorporating expert knowledge in tissue image annotation
F Kromp, I Ambros, T Weiss, D Bogen, H Dodig, M Berneder, T Gerber, ...
2016 23rd International Conference on Pattern Recognition (ICPR), 343-348, 2016
72016
Visualization of intra tumor heterogeneity by simultaneous analysis of tumor and liquid biopsy samples in stage M neuroblastomas
T Gerber, LJ Barber, SC Huetter, D Bogen, MN Davies, I Assiotis, ...
Klinische Pädiatrie 229 (03), A30, 2017
2017
Abstract B31: Combined siRNA and small molecule screening identifies Aurora B kinase as an effective target in MYCN-driven neuroblastoma
D Bogen, JS Wei, DO Azorsa, P Ormanoglu, E Buehler, R Guha, JM Keller, ...
Cancer Research 76 (5_Supplement), B31-B31, 2016
2016
Abstract B56: Genomic background of neuroblastomas with intratumor heterogeneity of MYCN amplification
IM Ambros, C Brunner, D Bogen, G Amann, R Abbasi, B Gürtl-Lackner, ...
Cancer Research 74 (20_Supplement), B56-B56, 2014
2014
Genomic background of neuroblastomas with intratumour heterogeneity of MYCN amplification
PF Ambros, D Bogen, C Brunner, G Amann, B Guertl-Lackner, R Abbasi, ...
EUROPEAN JOURNAL OF CANCER 49, S351-S351, 2013
2013
Synthetic lethal siRNA screening to identify novel combinational therapies with Topotecan in neuroblastoma.
D Bogen, EC Buehler, P Tuzmen, R Patidar, D Azorsa, YK Song, H Liao, ...
Cancer Research 73 (8_Supplement), 4398-4398, 2013
2013
Massively parallel transcriptome sequencing in neuroblastoma reveals specific mRNA splicing patterns controlled by RNA binding splicing factors.
S Zhang, T Badgett, J Wei, YK Song, D Bogen, P Johansson, C Tolman, ...
Cancer Research 73 (8_Supplement), 3161-3161, 2013
2013
Amplicon, genomic background and genome instability in heterogeneous MYCN amplified neuroblastoma
D Bogen, IM Ambros, G Amann, E Spuller, J Erichsen, B Brunner, ...
Klinische Pädiatrie 222 (03), A17, 2010
2010
Die Hepatitis C Virus-induzierte Freisetzung inflammatorischer Chemokine führt zu einer präferenziellen Rekrutierung NKG2A-exprimierender CD8+ T Zellen
J Nattermann, R Sherzada, A Iwan, D Bogen, IM Niederle, D Schulte, ...
Zeitschrift für Gastroenterologie 46 (09), P092, 2008
2008
120 HEPATITIS C VIRUS-INDUCED SECRETION OF INFLAMMATORY CHEMOKINES PREFERENTIALLY RECRUIT NKG2A EXPRESSING CD8 T CELLS
J Nattermann, R Sherzada, A Iwan, D Bogen, IM Niederle, D Schulte, ...
Journal of Hepatology 48 (2), 5, 2008
2008
[456] NKG2A-POSITIVE CD8+ T CELLS IN CHRONIC HEPATITIS C
J Nattermann, R Sherzada, D Bogen, A Iwan, HD Nischalke, B Kramer, ...
Journal of Hepatology, S173-S174, 2007
2007
Charakterisierung NKG2A-positiver CD8+ T bei der HCV-Infektion
J Nattermann, R Sherzada, D Bogen, A Iwan, HD Nischalke, B Krämer, ...
Zeitschrift für Gastroenterologie 45 (01), A4_18, 2007
2007
CHARACTERIZATION OF NKG2A-POSITIVE CD8+ T CELLS IN HCV INFECTION: 414
J Nattermann, R Sherzada, D Bogen, A Iwan, HD Nischalke, B Krämer, ...
Hepatology 44, 345A, 2006
2006
系统目前无法执行此操作,请稍后再试。
文章 1–18